Sense4Care, in collaboration with the Research Area of CSAPG, has obtained funding to lead the new MoMoPa-AM project. This project, prominently driven by Sense4Care’s commitment to advancing healthcare technology, focuses on enhancing mobility monitoring in patients with Parkinson’s disease.
This significant venture is a continuation of the MoMoPa series of studies on Parkinson’s disease, initiated in 2009. It is part of a competitive joint call for R&D projects funded by the Instituto de Salud Carlos III (ISCIII) and the Centro para el Desarrollo Tecnológico y la Innovación (CDTI). The arrangement supports two distinct coordinated projects with separate budgets and objectives: the research-focused project managed by CSAPG and funded by ISCIII, and the business-oriented project led by Sense4Care with CDTI funding.
With a strong emphasis on collaboration, the project brings together neurology experts from various institutions across the country, predominantly featuring contributions from Sense4Care alongside those from CSAPG. The total funding for both projects is approximately 500,000 euros, marking a strategic effort to drive advancements in the treatment and management of Parkinson’s disease.
The MoMoPa-AM study aims to provide a better understanding and identification of the symptoms associated with Parkinson’s disease, enabling more personalized and precise intervention in patient treatment. To launch this project, cutting-edge technologies will be used, including specialized sensors to collect objective data on patient mobility.
The proposed methodology is based on creating a database with 100 patients who will be monitored with sensors for a minimum of six hours each. From this database, an algorithmic block will be developed capable of detecting and assessing motor symptoms of Parkinson’s disease automatically, using only the sensor signals, even when the patient is not moving.
The results of this project will drive the development of an innovative product capable of performing comprehensive monitoring of the motor symptoms of Parkinson’s disease. Currently, there is no monitoring system available that can measure these symptoms without the need for the patient to move.
